Dylan Dupuis
Stock Analyst at Roth MKM
(2.78)
# 1,928
Out of 4,915 analysts
8
Total ratings
50%
Success rate
43.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dylan Dupuis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMMB Chemomab Therapeutics | Reinstates: Buy | $7 | $1.07 | +554.21% | 2 | Dec 19, 2023 | |
| IVA Inventiva | Reiterates: Buy | $11 | $3.35 | +228.85% | 2 | Sep 21, 2023 | |
| TERN Terns Pharmaceuticals | Reiterates: Buy | $23 | $5.83 | +294.51% | 3 | Aug 8, 2023 | |
| VKTX Viking Therapeutics | Assumes: Buy | $32 | $32.57 | -1.75% | 1 | May 31, 2023 |
Chemomab Therapeutics
Dec 19, 2023
Reinstates: Buy
Price Target: $7
Current: $1.07
Upside: +554.21%
Inventiva
Sep 21, 2023
Reiterates: Buy
Price Target: $11
Current: $3.35
Upside: +228.85%
Terns Pharmaceuticals
Aug 8, 2023
Reiterates: Buy
Price Target: $23
Current: $5.83
Upside: +294.51%
Viking Therapeutics
May 31, 2023
Assumes: Buy
Price Target: $32
Current: $32.57
Upside: -1.75%